title: Oncostatin M stimulates expression of stromal-derived factor-1 in human mesenchymal stem cells.
abstract: Stromal-derived factor-1 (SDF-1) is a CXC chemokine that attracts leukocytes and endothelial progenitor cells. In the present study, we demonstrated that oncostatin M (OSM) stimulates expression and secretion of SDF-1 in both human adipose tissue-derived mesenchymal stem cells (hATSCs) and bone marrow-derived mesenchymal stem cells. The OSM-stimulated expression of SDF-1 in hATSCs was completely abrogated by pretreatment of the cells with U0126, an MEK-specific inhibitor, but not with AG490, a JAK2 inhibitor, or WHI-P131, a JAK3 inhibitor, suggesting that ERK, but not JAK2 and JAK3, is involved in the OSM-induced expression of SDF-1. Pretreatment of hATSCs with anti-VEGF neutralizing antibody or VEGF receptor inhibitors, SU5416 and KRN633, had no significant impact on the OSM induction of SDF-1. Furthermore, treatment of hATSCs with recombinant human VEGF165 or adenoviral overexpression of VEGF did not increase the expression of SDF-1. These results suggest that OSM induces secretion of SDF-1 through ERK-, but not VEGF-, dependent signaling pathways in mesenchymal stem cells.
authors.affiliation: Medical Research Center for Ischemic Tissue Regeneration of Pusan National University & the Medical Research Institute, Busan 602-739, Republic of Korea.
authors.forename: Mi Jeong
authors.initials: MJ
authors.lastname: Lee
authors.forename: Hae Young
authors.initials: HY
authors.lastname: Song
authors.forename: Mi Ra
authors.initials: MR
authors.lastname: Kim
authors.forename: Sang-Min
authors.initials: SM
authors.lastname: Sung
authors.forename: Jin Sup
authors.initials: JS
authors.lastname: Jung
authors.forename: Jae Ho
authors.initials: JH
authors.lastname: Kim
mesh_terms: D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism; D001483:Base Sequence; D002070:Butadienes / Q000494:pharmacology; D002478:Cells, Cultured; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000096:biosynthesis* / Q000235:genetics*; D017931:DNA Primers / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D020935:MAP Kinase Signaling System / Q000187:drug effects; D059630:Mesenchymal Stem Cells / Q000187:drug effects* / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology; D053683:Oncostatin M / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
chemical_list: D002070:Butadienes; C515255:CXCL12 protein, human; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D017931:DNA Primers; D009570:Nitriles; C508351:OSM protein, human; D011994:Recombinant Proteins; C113580:U 0126; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D053683:Oncostatin M